APA (7th ed.) Citation

Bird, P., Hall, S., Nash, P., Connell, C. A., Kwok, K., Witcombe, D., & Thirunavukkarasu, K. (2019). Treatment outcomes in patients with seropositive versus seronegative rheumatoid arthritis in Phase III randomised clinical trials of tofacitinib. Rheumatic & musculoskeletal diseases open, 5(1), e000742. https://doi.org/10.1136/rmdopen-2018-000742

Chicago Style (17th ed.) Citation

Bird, Paul, Stephen Hall, Peter Nash, Carol A. Connell, Kenneth Kwok, David Witcombe, and Krishan Thirunavukkarasu. "Treatment Outcomes in Patients with Seropositive Versus Seronegative Rheumatoid Arthritis in Phase III Randomised Clinical Trials of Tofacitinib." Rheumatic & Musculoskeletal Diseases Open 5, no. 1 (2019): e000742. https://doi.org/10.1136/rmdopen-2018-000742.

MLA (9th ed.) Citation

Bird, Paul, et al. "Treatment Outcomes in Patients with Seropositive Versus Seronegative Rheumatoid Arthritis in Phase III Randomised Clinical Trials of Tofacitinib." Rheumatic & Musculoskeletal Diseases Open, vol. 5, no. 1, 2019, p. e000742, https://doi.org/10.1136/rmdopen-2018-000742.